Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

iwCLL 2017 | Do immunoglobulin receptor interactions play a role in CLL?

Paolo Ghia • 11 Aug 2017
iwCLL 2017
Chronic Lymphocytic Leukemia

Paolo Ghia, MD, PhD from the San Raffaele Hospital, Milan, Italy, provides us an overview of a prospective clinical study in which patients with chronic lymphocytic leukemia (CLL) are screened according to the affinity of their immunoglobulin receptors and then treated, with a long-term follow-up of 2-3 years. He expects that those with weak receptor interactions with respond well to therapy whereas those with strong interactions will not. This video was recorded at the International Workshop on Chronic Lymphocytic Leukemia (iwCLL) 2017 in New York, NY.

More from Paolo Ghia

1:21
Monoclonal B-cell lymphocytosis: a disease to be (or not to be)
Paolo Ghia • 7 Apr 2024
MBL: biology, classification & the possibility of early interception
Andrew Rawstron et al. • 25 Mar 2024
2:20
Monoclonal B-cell lymphocytosis: at a crossroad between disease and senescence
Paolo Ghia • 8 Dec 2023
3:00
Five-year follow-up of the CAPTIVATE trial: ibrutinib retreatment in patients with CLL
Paolo Ghia • 8 Dec 2023

Related Videos

3:18
A Phase I study of JBH492, an anti-CCR7 antibody-drug conjugate, in lymphoid malignancies
Pau Abrisqueta • 5 Apr 2024
0:44
Early detection and interception across hematological cancers
Irene Ghobrial • 8 Apr 2024
1:21
Monoclonal B-cell lymphocytosis: a disease to be (or not to be)
Paolo Ghia • 7 Apr 2024
Richter’s transformation: biology & ongoing trials in the field
Carsten Niemann et al. • 25 Mar 2024
The content of VJHemOnc is intended for healthcare professionals